Elevated circulating levels of CSF-1 have also been reported in some neoplastic malignancies, including AML, and appear to be associated with poor prognosis [57-60], further promoting the use of the SJL/J mouse in the study of the CSF-1's role in cancer. Here, CSF1 is linked to acute myeloid leukemia.